Orthofix Medical Inc. (OFIX): Price and Financial Metrics


Orthofix Medical Inc. (OFIX)

Today's Latest Price: $31.26 USD

0.40 (-1.26%)

Updated Oct 30 4:00pm

Add OFIX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 142 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

OFIX Stock Summary

  • OFIX's went public 28.54 years ago, making it older than 79.99% of listed US stocks we're tracking.
  • With a year-over-year growth in debt of 481.4%, Orthofix Medical Inc's debt growth rate surpasses 96.14% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Orthofix Medical Inc is reporting a growth rate of -633.42%; that's higher than just 3.02% of US stocks.
  • Stocks that are quantitatively similar to OFIX, based on their financial statements, market capitalization, and price volatility, are SPNE, ISR, PMD, KERN, and NTIC.
  • OFIX's SEC filings can be seen here. And to visit Orthofix Medical Inc's official web site, go to www.orthofix.com.

OFIX Stock Price Chart Interactive Chart >

Price chart for OFIX

OFIX Price/Volume Stats

Current price $31.26 52-week high $47.91
Prev. close $31.66 52-week low $22.11
Day low $30.58 Volume 117,800
Day high $31.66 Avg. volume 135,509
50-day MA $31.26 Dividend yield N/A
200-day MA $33.45 Market Cap 604.19M

Orthofix Medical Inc. (OFIX) Company Bio


Orthofix International provides reconstructive and regenerative orthopedic and spine solutions to physicians. It operates through four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The company was founded in 1987 and is based in Willemstad, Curaçao.

OFIX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$31.26$10.93 -66%

We started the process of determining a valid price forecast for Orthofix Medical Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Orthofix Medical Inc ranked in the 22th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Orthofix Medical Inc, consider:

  • In the past 5.28 years, Orthofix Medical Inc has a compound free cash flow growth rate of 0.01%; that's higher than only 21.78% of free cash flow generating stocks in the Healthcare sector.
  • Orthofix Medical Inc's interest coverage rate -- a measure of gross earnings relative to interest payments -- comes in at -19.54. This coverage rate is greater than that of merely 5.7% of stocks we're observing for the purpose of forecasting via discounted cash flows.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-66%
1%-66%
2%-66%
3%-65%
4%-65%
5%-65%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as OFIX, try BAX, HOLX, MDT, SRDX, and TMO.


OFIX Latest News Stream


Event/Time News Detail
Loading, please wait...

OFIX Latest Social Stream


Loading social stream, please wait...

View Full OFIX Social Stream

Latest OFIX News From Around the Web

Below are the latest news stories about Orthofix Medical Inc that investors may wish to consider to help them evaluate OFIX as an investment opportunity.

Earnings Preview: Orthofix (OFIX) Q2 Earnings Expected to Decline

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

Orthofix Schedules Second Quarter 2020 Earnings Release and Conference Call for August 6, 2020

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarter 2020 before market open on Thursday, August 6, 2020. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m. ET the same day.

Yahoo | July 27, 2020

Orthofix JuniOrtho Plating System Gets Regulatory Clearances

Orthofix (OFIX) rides high on dual regulatory clearances for its deformity correction system, thus solidifying its pediatric orthopedics portfolio.

Yahoo | July 21, 2020

If You Had Bought Orthofix Medical's (NASDAQ:OFIX) Shares A Year Ago You Would Be Down 37%

Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can...

Yahoo | July 20, 2020

Orthofix Receives FDA Clearance and CE Mark for the JuniOrtho Plating System

Orthofix's JuniOrtho Plating System for pediatric deformity correction and trauma reconstruction receives FDA clearance and CE Mark approval.

Yahoo | July 20, 2020

Read More 'OFIX' Stories Here

OFIX Price Returns

1-mo -0.41%
3-mo 1.79%
6-mo -6.80%
1-year -24.70%
3-year -40.38%
5-year -11.27%
YTD -32.31%
2019 -12.02%
2018 -4.04%
2017 51.19%
2016 -7.73%
2015 30.44%

Continue Researching OFIX

Here are a few links from around the web to help you further your research on Orthofix Medical Inc's stock as an investment opportunity:

Orthofix Medical Inc (OFIX) Stock Price | Nasdaq
Orthofix Medical Inc (OFIX) Stock Quote, History and News - Yahoo Finance
Orthofix Medical Inc (OFIX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8976 seconds.